CrossrefInfokarte
Chemotherapy-free phase 1/2 trial of HRS-4642 plus adebrelimab in previously treated metastatic KRAS G12D-mutant pancreatic cancer
Cancer Cell · 2026-10 · 44 (10) · 2100-2107.e2
DOI: 10.1016/j.ccell.2026.08.012 ↗Abstract
Kein Abstract verfügbar.
EUVIMED